Treatment of acute bronchospasm in elderly patients.
Both asthma and chronic obstructive pulmonary disease (COPD) are often underdiagnosed and undertreated among the elderly. Patient compliance with treatments plans and medication schedules are often less than ideal. This paper presents results from clinical studies examining levalbuterol and racemic albuterol use among elderly patients who have asthma or COPD.
Berger
William E
WE
Department of pediatrics, division of allergy and immunology, College of Medicine, University of California, Irvine, USA. weberger@uci.edu
D000208:Acute Disease; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging; D000420:Albuterol / Q000627:therapeutic use; D001249:Asthma / Q000150:complications / Q000188:drug therapy*; D001294:Attitude to Health; D001986:Bronchial Spasm / Q000188:drug therapy* / Q000209:etiology; D001993:Bronchodilator Agents / Q000627:therapeutic use; D006801:Humans; D055118:Medication Adherence / Q000523:psychology; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000188:drug therapy*
D000305:Adrenal Cortex Hormones; D001993:Bronchodilator Agents; D000420:Albuterol